1. Home
  2. RNXT vs SLGL Comparison

RNXT vs SLGL Comparison

Compare RNXT & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • SLGL
  • Stock Information
  • Founded
  • RNXT 2012
  • SLGL 1997
  • Country
  • RNXT United States
  • SLGL Israel
  • Employees
  • RNXT N/A
  • SLGL N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNXT Health Care
  • SLGL Health Care
  • Exchange
  • RNXT Nasdaq
  • SLGL Nasdaq
  • Market Cap
  • RNXT 31.6M
  • SLGL 17.0M
  • IPO Year
  • RNXT 2021
  • SLGL 2018
  • Fundamental
  • Price
  • RNXT $1.12
  • SLGL $0.59
  • Analyst Decision
  • RNXT Strong Buy
  • SLGL Strong Buy
  • Analyst Count
  • RNXT 1
  • SLGL 2
  • Target Price
  • RNXT $9.00
  • SLGL $5.00
  • AVG Volume (30 Days)
  • RNXT 209.0K
  • SLGL 69.1K
  • Earning Date
  • RNXT 03-31-2025
  • SLGL 03-12-2025
  • Dividend Yield
  • RNXT N/A
  • SLGL N/A
  • EPS Growth
  • RNXT N/A
  • SLGL N/A
  • EPS
  • RNXT N/A
  • SLGL N/A
  • Revenue
  • RNXT N/A
  • SLGL $11,707,000.00
  • Revenue This Year
  • RNXT N/A
  • SLGL $772.97
  • Revenue Next Year
  • RNXT N/A
  • SLGL N/A
  • P/E Ratio
  • RNXT N/A
  • SLGL N/A
  • Revenue Growth
  • RNXT N/A
  • SLGL 869.93
  • 52 Week Low
  • RNXT $0.77
  • SLGL $0.33
  • 52 Week High
  • RNXT $1.86
  • SLGL $1.65
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 40.17
  • SLGL 37.99
  • Support Level
  • RNXT $1.00
  • SLGL $0.56
  • Resistance Level
  • RNXT $1.18
  • SLGL $0.64
  • Average True Range (ATR)
  • RNXT 0.10
  • SLGL 0.09
  • MACD
  • RNXT -0.03
  • SLGL -0.02
  • Stochastic Oscillator
  • RNXT 24.00
  • SLGL 14.52

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Share on Social Networks: